Loading...
OTCM
CRLBF
Market cap273mUSD
Dec 05, Last price  
0.80USD
1D
-7.57%
1Q
-32.99%
IPO
-81.47%
Name

Cresco Labs Inc

Chart & Performance

D1W1MN
OTCM:CRLBF chart
P/E
P/S
0.38
EPS
Div Yield, %
Shrs. gr., 5y
23.90%
Rev. gr., 5y
41.31%
Revenues
724m
-6.04%
000000000003,157,23210,310,00043,252,000128,534,000476,251,000821,682,000842,681,000770,885,000724,343,000
Net income
-74m
L-57.59%
000000000047,37700-1,915,000-65,302,000-36,562,000-296,834,000-215,843,000-175,522,000-74,438,000
CFO
132m
+126.21%
000000034,8140083,507029,916-9,916,000-25,189,000-10,831,00014,487,00018,741,00058,564,000132,480,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of December 6, 2022, it owned and operated 55 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.
IPO date
Dec 03, 2018
Employees
3,000
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122018‑012017‑012016‑01
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT